Valuation : Becton, Dickinson and Company

Market Cap 51.62B 44.45B 41.73B 38.1B 71.57B 4,912B 72.08B 495B 192B 2,491B 194B 190B 8,247B P/E 2026 *
36.5x
P/E 2027 * 20.4x
Enterprise Value 67.51B 58.12B 54.58B 49.82B 93.59B 6,423B 94.26B 647B 252B 3,257B 253B 248B 10,785B EV / Sales 2026 *
3.5x
EV / Sales 2027 * 3.32x
Free-Float
73.18%
Yield 2026 *
2.07%
Yield 2027 * 2.11%
1 day-0.69%
1 week-1.47%
Current month+13.48%
1 month+13.48%
3 months+29.32%
6 months+7.88%
Current year-3.16%
1 week 186.62
Extreme 186.62
191.52
1 month 166.8
Extreme 166.8
193.07
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
281
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
8/26/26 Sell

Executive/Senior Manager

-165 0.0001%
8/20/26 Tax

Executive/Senior Manager

-1,049 0.0004%
8/13/26 Exercice

Chief Executive Officer

129,834 0.0471%
Change 5-day change 1-year change 3-year change Capi.($)
-0.68%-1.47%-0.11%-32.75% 51.62B
-1.73%-5.37%-16.02%+7.29% 195B
-0.25%-2.17%-2.63%+11.51% 117B
+0.60%-0.02%+9.78%+83.94% 61.45B
+0.80%-1.18%+27.79%+52.56% 51.03B
-0.56%-0.80%+21.57%-10.55% 34.27B
+1.01%+2.07% - - 30.95B
+1.43%-3.09%+40.48%-15.85% 23.75B
-0.91%-2.06%-5.54%+16.29% 23.41B
-0.69%-2.48%-4.16%+1.03% 22.79B
Average -0.10%-1.39%+7.91%+12.61% 61.07B
Weighted average by Cap. -0.52%-1.95%+0.11%+14.80%

Financials

2026 *2027 *
Net sales 19.29B 16.61B 15.6B 14.24B 26.74B 1,836B 26.94B 185B 71.9B 931B 72.43B 70.86B 3,082B 19.73B 16.99B 15.95B 14.56B 27.36B 1,878B 27.55B 189B 73.55B 952B 74.09B 72.48B 3,152B
Net income 1.44B 1.24B 1.16B 1.06B 1.99B 137B 2.01B 13.76B 5.35B 69.32B 5.39B 5.28B 230B 2.34B 2.01B 1.89B 1.73B 3.24B 223B 3.27B 22.41B 8.72B 113B 8.78B 8.59B 374B
Net Debt 15.88B 13.68B 12.84B 11.72B 22.02B 1,511B 22.18B 152B 59.21B 766B 59.64B 58.35B 2,538B 13.95B 12.01B 11.28B 10.3B 19.34B 1,327B 19.48B 134B 52B 673B 52.38B 51.25B 2,229B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-08-31 $188.02 -0.79% 706,182
26-08-28 $189.52 +0.74% 1,693,786
26-08-27 $188.13 -1.09% 1,354,083
26-08-26 $190.21 +0.23% 1,403,112
26-08-25 $189.78 -0.50% 1,207,516
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
189.52USD
Average target price
195.67USD
Spread / Average Target
+3.24%

Quarterly revenue - Rate of surprise